This Article  • References  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Tommaso Caraceni, MD
Department of Neurology

Mario Savoiardo, MD; Marina Grisoli, MD
Department of Neuroradiology

Daniela Testa, MD; Floriano Girotti, MD
Department of Neurology Istituto Nazionale Neurologico "C. Besta" Via Celoria 11 20133 Milan, Italy

Arch Neurol. 1996;53(3):212.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with interest the article on multiple system atrophy (MSA) by Colosimo et al¹ that appeared in the March 1995 issue of the ARCHIVES and completely agree with them about the clinical criteria used for the diagnosis of possible or probable MSA. However, we believe that the contribution offered by magnetic resonance imaging (MRI) cannot now be disregarded. The studies we made at the Istituto Nazionale Neurologico "C. Besta," Milan, Italy, on the neuroradiologic aspects of MSA^2-4 and on the correlations between the clinical presentation and the findings from an MRI in a large series of patients with MSA, including the varieties of striatonigral degeneration and olivopontocerebellar atrophy,^5,6 clearly demonstrate the great value of MRI in the diagnosis of MSA.

In striatonigral degeneration, low-signal intensity in T₂-weighted images at high-field intensity MRI (1.5 T) can be demonstrated in the putamen, principally in the posterolateral . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?